Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 26.04 million as of May 13, 2025. Its market cap has increased by 146.66% in one year.

Market Cap

26.04M

Enterprise Value

41.89M

Revenue

25.70M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.50

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 26.04M, a decrease of -84.66%. That is a compound annual growth rate of -18.41%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	28.02M	32.71%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	74.69M	-64.39%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	159.28B
GSK plc	56.88B
Haleon	36.42B
Smith & Nephew	9.45B
ConvaTec Group	5.36B
Hikma Pharmaceuticals	4.31B
HUTCHMED (China)	1.83B
Genus	1.39B

Market Cap Rankings